Cargando…

2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)

BACKGROUND: Current first-line (first) antifungal treatment for invasive mucormycosis (IM) consists of liposomal amphotericin B (AMB). Salvage (SAL) treatment options are limited and often based on posaconazole oral suspension (POSsusp). However, with the approval of posaconazole new formulations (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salmanton-Garcia, Jon, Seidel, Danila, Koehler, Philipp, Mellinghoff, Sibylle, Wisplinghoff, Hilmar, Vehreschild, Jörg, Cornely, Oliver, Vehreschild, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809098/ http://dx.doi.org/10.1093/ofid/ofz360.1799

Ejemplares similares

2046. FungiScope™: News on the Global Emerging Fungal Infection Registry
por: Seidel, Danila, et al.
Publicado: (2018)

403. Prognostic Factors in 260 Adults With Invasive Scedosporiosis From Literature and FungiScope™
por: Seidel, Danila, et al.
Publicado: (2018)

1172. Mucormycosis Treated with Isavuconazole: A matched-Pair Analysis from the FungiScope(®) Registry
por: Seidel, Danila, et al.
Publicado: (2020)

Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2018)

Metadata Correction: Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study
por: Mellinghoff, Sibylle C, et al.
Publicado: (2019)

412. Clinical and Pharmacoeconomic Evaluation of Antifungal Prophylaxis With Continuous Micafungin Compared to Posaconazole With Micafungin Bridging in Patients Undergoing Allogeneic Stem Cell Transplantation: A 6-Year Cohort Analysis
por: Heimann, Sebastian M, et al.
Publicado: (2018)

Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic
por: Schumacher, Sofie, et al.
Publicado: (2023)

372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018)

Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect
por: Schumacher, Sofie, et al.
Publicado: (2020)

1236. Staphylococcus aureus Surgical Site Infection: Epidemiology in Europe (SALT)
por: Mellinghoff, Sibylle, et al.
Publicado: (2019)

1568. Implementation of a Standard Diet Regimen for Neutropenic High-Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome
por: Jakob, Carolin, et al.
Publicado: (2018)

413. Intravenous and Tablet Formulation of Posaconazole in Antifungal Therapy and Prophylaxis: A Retrospective, Non-Interventional, Multicenter Analysis of Patients Treated in German Tertiary-Care Hospitals
por: Heimann, Sebastian M, et al.
Publicado: (2018)

Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: Yuan, F., et al.
Publicado: (2021)

Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection—A Prospective Pilot Study
por: Koehler, Felix C., et al.
Publicado: (2018)

Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole
por: Ding, Xiao-Lan, et al.
Publicado: (2020)

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
por: Stemler, Jannik, et al.
Publicado: (2020)

Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope(®) registry
por: Sal, Ertan, et al.
Publicado: (2022)

Harmonized procedure coding system for surgical procedures and analysis of surgical site infections (SSI) of five European countries
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study
por: Mellinghoff, Sibylle, et al.
Publicado: (2023)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

Fatal Breakthrough Mucormycosis in an Acute Myelogenous Leukemia Patient while on Posaconazole Prophylaxis
por: Kang, Seung Hun, et al.
Publicado: (2015)

Clostridioides difficile infections in the intensive care unit: a monocentric cohort study
por: Aguilar, Rebeca Cruz, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in CLL: how often is enough?
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation
por: Belling, Morgan, et al.
Publicado: (2017)

Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
por: Kayarat, Bhavana, et al.
Publicado: (2021)

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
por: Cornely, Oliver A., et al.
Publicado: (2016)

Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study
por: Biehl, Lena M., et al.
Publicado: (2022)

Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries
por: Pana, Zoi Dorothea, et al.
Publicado: (2016)

Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
por: Leelawattanachai, Pannee, et al.
Publicado: (2019)

PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma
por: Hawley, DP, et al.
Publicado: (2013)

Origin and Evolutionary Dynamics of the miR2119 and ADH1 Regulatory Module in Legumes
por: De la Rosa, Carlos, et al.
Publicado: (2020)

Acute Kidney Injury Following Posaconazole for Mucormycosis: SARS-CoV-2 as a Back-Seat Driver
por: Noor, Mohammad, et al.
Publicado: (2022)

Posaconazole for lobomycosis
por: Pasqualotto, Alessandro C., et al.
Publicado: (2021)

PB2119: REDUCED OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS DURING THE COVID-19 PANDEMIC
por: Luchinin, Alexander, et al.
Publicado: (2023)

Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
por: Schmidt-Hieber, M., et al.
Publicado: (2017)

Oral posaconazole and bronchoscopy as a treatment for pulmonary mucormycosis in pediatric acute lymphoblastic leukemia patient: A case report
por: Liang, Yan, et al.
Publicado: (2021)

Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series
por: Soman, Rajeev, et al.
Publicado: (2022)

The use of posaconazole delayed-release tablets in the successful treatment of suspected mucormycosis in a bottlenose dolphin (Tursiops truncatus) calf
por: Marques, Gonçalo N., et al.
Publicado: (2021)

Mucormycosis in a Severe Trauma Patient Treated with a Combination of Systemic Posaconazole and Topical Amphotericin B—Case Report
por: Keller, Filip, et al.
Publicado: (2023)

Optimization of Oral Posaconazole Step Down Therapy in Management of Rhino-Orbital-Cerebral Mucormycosis (ROCM): Outcome of an Institutional Protocol
por: Mukherjee, Monoj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pls2ls3arpe92njli0bk90r8mm